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ABSTRACT
Bioprospecting has been on the agenda for discussion by the government, the academic
community, businesses and other pertinent actors for many years now; it is an integral
topic representing a potential approach to exploit biodiversity to the fullest. This
document presents some definitions of what bioprospecting is (some restrictive, others
with a broader perspective, depending on different approaches, actors, target markets
and countries) in the context of a mechanism for development and cooperation
concerning the construction of capacities, advantages and disadvantages. It was found
that bioprospecting in Colombia has been developing from a broad perspective
(systematic study of biological-genetic resources, transformation into a product which
has led to strengthening some value chains, small- and/or large-scale marketing and
some advances in intellectual property rights and the distribution of benefits) in order
to provide greater benefits for the nation. 
Keywords: prospecting biological diversity, technical capacity.
RESUMEN
La bioprospección ha sido durante varios años tema de discusión por los gobiernos, la
comunidad académica, las empresas, y otros actores que se integran en el proceso,
como potencial de acercamiento y uso de la diversidad biológica. A través del presente
documento se presentan algunas definiciones de lo que es la bioprospección (algunas
restrictivas otras de perspectiva amplia, dependientes de diferentes aproximaciones,
actores, blanco de mercado, contexto del país, entre otros), la bioprospección como
mecanismo de desarrollo y cooperación para la construcción de capacidades, ventajas
y desventajas. Se encuentra que en Colombia se ha venido desarrollando bioprospec-
ción desde la perspectiva amplia (estudio sistemático del recurso biológico-genético,
transformación en un producto lo que ha permitido el fortalecimiento de algunas ca-
denas de valor, comercialización a pequeña o gran escala y algunos avances en temas
de propiedad intelectual y distribución de beneficios) lo cual puede brindar mayores
beneficios para la nación. 
Acta biol. Colomb., Vol. 18 n.º 1, 2013   19 - 30
Palabras clave: capacidades técnicas, prospección de la diversidad biológica. 
Colombia has a lot of biodiversity, being one of the ten megadiverse countries of the
world; and possesses diversity in the terrestrial and marine ecosystems and a unique
geostrategic position, with transport routes to the markets of Latin America, the United
States, the Caribbean, Europe, China, Japan, and India, among others. The diversity of
the biological and genetic resources of Colombia has competitive advantages at the
national and international levels. The Convention on Biological Diversity CBD (which
came into force in December of 1993, approved by Law 165 of 1994) set the following
objectives: a) conservation of biological diversity; b) sustainable use of its components,
and c) fair and equitable sharing of benefits arising from its use.
The national biodiversity policy requires action such as education, public participation,
legislative and institutional development, and economic valuation, among others. In
accordance with the commitments undertaken by signing the CBD, the member countries
of the Cartagena Agreement or Andean Pact, adopted a legal regime for access to genetic
resources, Decision 391 of 1996. It is worth noting that the indigenous, black and
farming communities living in close dependence with biological and genetic resources
have contributed to their preservation and should share in the benefits derived from their
economic and social development (Melgarejo et al., 2002a; Melgarejo et al., 2002b).
In 2010, the Nagoya Protocol on access to genetic resources and the fair and equitable
sharing of benefits arising from the use of biodiversity was adopted. The Protocol
promotes the third objective of the Convention, creating legal elements for both
providers and users of genetic resources (Secretaría del Convenio sobre la Diversidad
Biológica, 2011). Strategies have been developed to access, understand and use
biological-genetic resources. Humans, throughout history, have sought to understand
the resources in their environment and use or apply them for food, health, and cosmetics,
among others; developing industries such as those for food, pharmaceuticals, medical
botany, crop protection, etc. These developments involve bioprospecting.
There are various definitions of bioprospecting, depending on the different approaches
(researchers, communities, businesses, governments), the country and its context, the
market, and the level of technological development (technology leading countries vs.
non-technology leading ones that are rich in biodiversity) (Melgarejo, 2003; Duarte et
al., 2006; Duarte and Velho, 2008; Duarte and Velho, 2009). Some are restrictive to
activities such as systematically searching for genes, chemical compounds, proteins and
other metabolites that may have potential economic value; others have a broad pers-
pective and include traditional knowledge, the systematic search for and characterization
of biological-genetic resources (genes, primary and secondary metabolites); to determine
and evaluate the biological action of the active elements, to develop products, to market
them, and to protect them with intellectual property rights and the participation of actors
at different stages of the process, among others.
Some definitions are mentioned by Melgarejo et al., 2002a and Melgarejo et al., 2002b,
others are presented below:
— Searching for information in biological species for later use in the production
processes of various sectors. An example of which is the information contained in the
genetic material of all living beings (genetic prospecting), in the chemical compounds
they produce (chemical prospecting) or in traditional knowledge (Alatorre, 1995).
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— A way to compensate countries for the use of their genetic resources which have natural
components by mainly the chemical and pharmaceutical industries (Brush, 1999).
— A process that involves three stages: understanding and characterizing the biological-
genetic resources, converting it into a product (for use in medicine, food, agriculture
or other) and marketing it (Melgarejo, 2003).
— An activity of nature exploration, non-destructive, which, through scientific research,
aims to obtain useful information derived from the collection of small quantities
of biological material for application in medicine, agriculture and industry (Setzer
et al., 2003).
— The systematic search of genes, chemical compounds, proteins and other products
that have an actual or potential economic value and are the components of biological
diversity, to gain a potential for product development (Castree, 2003).
— A process that involves four steps: sample collection; isolation, characterization and
culture; screening for pharmaceutical activity; development of product, patenting,
trials, sales and marketing (Jabour-Green and Nicol, 2003).
— The characterization of biological material in its various components, along with a
projection to protect the interests of intellectual property and develop a marketing
process for new products which may include modifying the chemical structure to
increase efficiency (Bull, 2004).
— The systematic search for the development of new biological sources which may have
commercial value, including all organisms, genes, chemicals, extracts, and other
products of nature; and the sustainable use of biological resources through
biotechnology and scientific and socioeconomic development of source countries
and local communities (Quesada, 2007).
Duarte and Velho (2008) reported that in bioprospecting, “an interaction can occur between
different types of knowledge, especially traditional knowledge held by indigenous and local communities
in countries rich in biodiversity and scientific or technological knowledge of academic and research
sectors that operate on their own or at the service of transforming companies, primarily those of
pharmaceutical and agro-input industries of technology leading countries. This confluence is
characterized by divergent motivations and interests between actors with very different powers, resulting
in the need to have regulatory frameworks that help regulate this interaction” (p. 104 -105).
Colombia, through Conpes de Biotecnología 3697 of June 2011, framed the term bio-
prospecting with a restrictive perspective as the “systematic exploration and sustainability
of biodiversity to identify and secure new sources of chemical compounds, genes,
proteins, microorganisms and other products that have potential to be commercially
exploited”. However, Colombia should not focus only on restrictive activities, but, given
the global evolution of the definition of bioprospecting from different actors and
interests, and the trend of the country to promote bioprospecting, in the Colombian
context, bioprospecting should be carried out with a broad perspective to strengthen
processes involving scientific, political, politico-economic and socio-environmental-
ethical spheres as an alternative for Colombian social welfare. It is of utmost importance
to include communities for regional development which is vital for growth with equity,
participation of the various actors in the monetary and non-monetary benefits,
consolidation of value chains, that could boost the domestic industry and generate
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employment through the development and strengthening of sectors such as agribusiness
(natural products, bio-products, enzymology), cosmetics, pharmaceuticals and medical
botany or others that, though prior country and conditions market research, show
profitability; with projected or determined plans for manufacturing, mass production
and marketing of the product; the calculated added economic value, the calculated
potential royalties and the distribution of benefits to different stakeholders including
communities; the protection under intellectual property rights of the characterized com-
ponents, the obtained products, the new developments or other substances obtained
from the basic metabolites or components derived from the biological-genetic resource
base; among other elements that can be added with public policy, participatory action
of the bioprospecting actors, and interdisciplinary and multidisciplinary analysis;
thereby creating bargaining power with technology leading countries.
It is considered as potentially harmful for the country to establish a national biopros-
pecting company engaged only in activities stated by the restrictive definition of Conpes
3697 of June 2011 without compulsory generation of value added products, that could
be used and/or marketed in various regions of the country or abroad, technology transfer
and other benefits for the nation that have been mentioned above when working with a
broad perspective. Additionally, it is necessary to note that in other countries where
bioprospecting has been done with a restrictive view, the monetary and nonmonetary
benefits that were expected have not been generated, and that Colombia confers some
resources in concessions which could lead to the detriment of the property of the nation
and the communities in general.
Duarte et al. (2006), in a review of Bioprospecting as a cooperation mechanism for
endogenous capacity building in science and technology and analysis of the capabilities
of Colombia to advance bioprospecting processes, reported that the main motivations
and interests of biodiversity-rich countries are: 1) The possibility of the participating
research groups and the domestic product involved in the process gaining worldwide
recognition, 2) Strengthening research infrastructure (equipment, laboratories), 3) The
potential for human resource training, 4) Strengthening negotiating skills; 5) Access to
knowledge, specialized software and complementary techniques, through technology
transfer processes; 6) In the case of achieving product marketing , economic benefits are
expected through the payment of royalties; 7) The ability to generate new employment
opportunities through the commercialization of products resulting from the process.
While the principal motivations of the leading countries in technology are related to: 1)
Increased sales of value added products, 2) The diversification of raw materials, which
will supply the company with a competitive advantage, 3) Access to different and
suitable agroecosystems of the tropic zones; 4) The possibility of intellectual property
rights for the obtained products. The authors mention that the majority of motivations
of countries rich in biodiversity are related to access and strengthening different kinds
of knowledge and skills; while the motivations of the leading countries in technology are
commercial. The authors consider bioprospecting as a formal cooperation mechanism
among leading countries in technology and technology dependent countries rich in
biodiversity with the objective of strengthening national endogenous capacities in
science and technology (p. 5-6). However, Duarte et al. (2006) concluded that after
more than a decade with the CBD, it has yet to produce the expected economic benefits
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for biodiversity-rich countries to strengthen their capacities in science and technology.
This is likely due to the limited capacity of negotiation by diversity rich countries
because, in many of these countries, the priority for researchers is to form alliances with
international technology leaders and joint publications in recognized journals, rather
than the development of products that could be protected by patents and lead to
monetary profit.
Literature reports indicate that the current scientific and technological capacity of
Colombia to address bioprospecting processes is represented by several research
groups, which means that this capacity must be strengthened (Melgarejo et al., 2002a;
Duarte et al., 2006), both regionally and nationally, with a strategy of specific measures
of science and technology policy. Up to 2002, there were mainly collections, taxonomic
studies for biodiversity inventories and chemical characterizations of some molecules;
afterwards, as part of the advances in bioprospecting, these activities continued, but
with the determination of biological activities without taking into account their
commercial potential. Today, in addition to determining the biological activities, the
potential has to be seen in order to be exploited commercially and produce some
products on a pilot scale, but aspects of intellectual property have barely been touched.
Several groups have developed capabilities mainly in genomics and bioinformatics,
followed by metabolomics, transcriptomics and some for proteomics; furthermore,
some capabilities in product development with potential for different industries have
been observed.
In this vein, funding has been given by centers of excellence: 1) in 2004, “Comprehensive
study of promising tropical aromatic and medicinal species for the development of
competitive and sustainable agribusiness essences, extracts and natural derivatives in
Colombia” by the Centro Nacional de Investigaciones para la Agroindustrialización de
Especies Vegetales Aromáticas y Medicinales Tropicales, CENIVAM. 2) in 2007,
“Formation of a metagenomic and bioinformatic platform for characterization and
utilization of genetic resources of extreme environments”, by the Centro Colombiano de
Genómica y Bioinformática de Ambientes Extremos, GeBiX. Similarly, funding for
knowledge networks has been generated, in 2012: 1) Bioprospecting and development
of natural ingredients for cosmetic, pharmaceutical and hygiene products, based on
Colombian biodiversity. 2) Red Nacional para la Bioprospección de Frutas Tropicales
RIFRUTBIO, where partnerships are made primarily for national groups and also
international groups.
Caraballo (2010) conducted an assessment of the benefits of bioprospecting activities
undertaken by centers of excellence and a research institute, concluding that: 1) none of
the cases included indigenous, local, or black communities, 2) the need to establish more
partnerships to develop bioprospecting activities and generate greater benefits is notable,
3) benefits are mainly non-monetary (human resource training, infrastructure and
strengthening technology platforms), social benefits are at still very limited. This indicates
that, although bioprospecting is an alternative for growth and development for the
country; the government, the decision makers in science and technology policies, the
different sectors of society, the centers of excellence, the research centers, the universities
and the knowledge networks, among others, must advance participatory technology
development mechanisms directed towards sectors of society that are not favored.
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Although bioprospecting can be a high risk investment, since not necessarily everything
produced by bioprospecting will succeed in the market (sometimes after five, ten or 20
years, only 1 % is successful), it is quite possible that if there is success, there will be a
return of the investment to the country’s economic benefit. In the short and medium
term, non-monetary benefits are obtained, such as the strengthening of the science and
technology of the country (technical, scientific, infrastructure, knowledge networks,
strengthening of production or value chains, partnerships between national and regional
research groups, alliances with international groups, human resources training, regional
strengthening, education systems focused on science, engineering and social studies,
expertise in mechanisms of intellectual property law, negotiation skills, etc.).
In regards to research and use of biodiversity in Andean Community countries, Roca
(2004) reported that plant, animal and micro-organism bioprospecting is being
impacted by modern biotechnology and chemistry in the search for new sources of
components for the development of more effective biopharmaceuticals (e.g., second
generation vaccines: attenuated viruses, and third generation vaccines: viral proteins),
for the production of proteins of therapeutic interest (insulin, interferons, etc.), for
developing cosmetics, for the production of more effective methods in the diagnosis of
diseases for better productivity and management of agricultural crops and finally for the
use of genomic information in the implementation of individualized molecular medicine.
Furthermore, the author indicated that bioprospecting is the meeting point between
biotechnology and biodiversity, and so constitutes the principal focus of action of
modern biotechnology (Roca, 2004).
In Colombia, to advance bioprospecting activities, teamwork is needed that takes into
account the participatory elements of public policy from all sectors of society. Since the
government is vital to making an adequate legal regulatory framework (intellectual
property rights, access to biological-genetic resources, bargaining power), economic
(economic valuation, negotiation skills), social (involving communities, fair and equitable
sharing of benefits derived from biodiversity, associativity), environmental (ecosystem
conservation, cost-benefit), and educational (educational system geared for the sciences
and engineering, attracting people with initiative, creativity and innovation, and support
to integrate research centers, Colombian companies, and universities; continuous
human resources training).
The biodiversity of Colombia has been in the crosshairs; Duarte and Velho (2008)
reported that some foreign companies sought to take advantage of the regulations
issued early in 1997, in order to try to obtain the relevant permits for advance bio-
prospecting practices throughout Colombia, offering in return, some non-monetary
incentives represented by equipped laboratories, shared publications and training of
technical personnel in Colombia, which did not correspond to the potential value of the
biodiversity to which they would have had access.
Restrictions for collecting permits, research permits and access to genetic resources
have impeded Colombian bioprospecting contracts with foreign companies, and even
for Colombian researchers. However, although the restrictions on access to biological-
genetic resources have created disadvantages for the country, at the same time, they have
enabled Colombian groups to be the ones who study the biodiversity and prospects,
thus creating technical capabilities and advantages for future negotiations with
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technology leading countries. By the same token, it does not serve the national interest
to change the restrictive regime of Decision 391 of 1996 for one widely permissive and
governed by freedom of contracts and private autonomy, making the biological
resources the sovereign property of the States (CBD), which must be placed at the
service of the country.
Internationally, bioprospecting is primarily related to secondary metabolites at all
organismic levels (plants, animals, microorganisms) and ecosystems (marine and
terrestrial), due to the economic impact generated by the pharmaceutical industry, but
also involves the characterization of genomes and biological components for different
bioprospecting industries, using omic tools (genomics, transcriptomics, metabolomics,
proteomics, etc.), the integration of human resources in science and engineering for
such studies, the use of biotechnology and technology for required research processes,
product development and marketing, and the contribution of capital by companies.
The literature has documented some international bioprospecting models (Carrizosa,
2002) as a benchmark for Colombia. Carrizosa (2002) conducted an analysis and
concluded that bioprospecting projects are not sharing the benefits derived from
biodiversity fairly and equitably. Also, the objectives of conservation and sustainable
use of biodiversity of these projects are not very significant. In the analysis of the models
of the University of Lausanne (Switzerland) in Zimbabwe, CGIB of Chile, Argentina and
Mexico, GCIB Suriname, the author stated that the actors in the biodiversity-rich
countries are not treated as true bioprospecting partners by industrialized countries or
leaders in technology, and the bioprospecting activities taking place in countries rich in
biodiversity are limited to ensure that there is a constant source of samples, while
activities that add value to the product and provide a significant capital investment in
research are performed in leading biotech countries which would not be beneficial to
countries like Colombia because they have no chance of developing a strong technology
platform or negotiation skills, among others.
In regards to the Project of the National Institute of Cancer in Sarawak (Malaysia) and
INBio and multinational pharmaceutical and biotechnology companies in Costa Rica,
it was stated that “part of the capital investment and construction of local capacity can
take place in biodiversity-rich countries if they have the appropriate financial incentives
to establish strategic alliances with bioprospectors. INBio is a classic example of how
an organization can gain relatively important benefits for the conservation of
biodiversity, without the need to enlist the help of laws regulating access to genetic
resources. In countries with laws regulating access to genetic resources such as the
Philippines, it is seen that investment in constructing local capacity is available through
partnership contracts. This model symbolizes the sovereignty that the Philippine access
laws give biodiversity-rich countries and the opportunity to lead these negotiation
processes and the fair and equitable sharing of benefits at the local perspective.
However, the reality is, that despite local initiatives for capacity construction that may
have been inspired by organizations like the INBio and promoted by laws regulating
access to genetic resources, in any model of bioprospecting executed so far in
biodiversity-rich countries, the most significant capital investment and marketing of
products has been carried out in the laboratories of industries located in countries that
are technology leaders (Carrizosa, 2002).
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Given the above, and although there are advantages and disadvantages, it is important
for Colombia to continue working on building local capacity in relation to intellectual
property and the development of trading strategies to produce “close the gap”
technology that still separates countries that are rich in biodiversity from technology
leading countries.
To build and strengthen local capacity in Colombia, it is necessary to make a current
and motivated review for change, with the aim of making suggestions for the
advancement and development of the country. Considering the submissions made by
a group of international researchers who participated in the first meeting of bio-
prospecting for the development of the Colombian agricultural sector, coordinated by
Corpoica, held between 15 and 16 December of 2011 in Corpoica Tibaitatá-Colombia.
The author suggests that there are several elements that could be considered for
implementing or strengthening sectors such as agriculture, health and environment.
Since the process of bioprospecting involves various aspects (educational-social-
economic-political-environmental-ethical), the possibility of carrying out this process
depends on political-governmental decisions, organization, financing, and the active
participation of a large number of citizens (not just experts) who represent actors, with
multi - and interdisciplinary approaches to the construction of guidelines and imple-
mentation of different activities. Among the elements, there are: 1) Establish socially
relevant programs with defined goals, emphasizing and rewarding innovation; not pushing
for publication fees is often counterproductive if innovation and patents are desired;
maintaining the interface between research institutions, the intellectual property legal
authorities, entrepreneurs and investors, businesses, and government regulations,
educators and business schools, and communities in the regions; with focus on one goal
and commitment of all stakeholders, identifying capabilities and uniqueness of projects,
products and people; additionally, be realistic and carry out activities with the available
budget and time, and have commitment to the short, medium and long term returns
on investment and improve competitiveness in global markets. 2) Conduct national
projects that include these issues while promoting a culture of innovation, more
Research and Development, funding by companies or the state, use of research results
for different industries, strengthening of technology transfer from academia to industry
and promoting collaboration between different sectors by encouraging cooperation
and national industrial participation. 3) Organized and systematic studies using classic
and current techniques and basic and applied sciences, which can be used to obtain a
great number of useful results for different industries and therefore business opportunities,
which must have a technology platform with national and international cooperation for
various analyzes. The scope may be large initially and then taper in the viability and
function of detection assays. 4) Development and improvement of products. In universities
and research centers, there should be an office of technology transfer which takes
inventory of developed innovations, taking into account issues of intellectual property
(patents, etc.) and contacts with industry for marketing, thus, creating part of the
investment return. 5) Development of national infrastructure and economic development
for sustainability and minimal impact on the environment, with governance to attract
foreign investment, promotion of entrepreneurship and business creation, investment in
education and manufacturing better technology. 6) Recognition of a short-term product,
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product implementation in small and medium industries, integration with a value chain
(see the value, create the value and deliver the value to the product); with focus on the
commercial potential and not just research, and business development with an
international projection. 7) Development with the networking methodology. Network
of infrastructure and knowledge with academic agreements with national and interna-
tional universities and research centers; network of trade agreements with several national
and international companies, network of development capabilities depending on the
stage of bioprospecting carried out in collaboration with companies, universities or
research centers for technology transfer. Networking and interdisciplinarity between the
knowledgeable sectors is necessary in order to reduce the time and costs in product
development and marketing and forms of protection of intellectual property rights;
additionally allow analysis of natural sources with new technologies to increase the
potential for commercial use. 8) Sound legal framework and the decision by the country
on the issue of access to genetic resources, which are key to negotiation (non-disclosure
agreements, research collaboration agreements and other legal documents containing
aspects of intellectual property rights and distribution of benefits, including the commu-
nities of origin of the biological-genetic resource and the numbers of patents, trademarks,
licenses, etc.), are also vital. The factors of success are related to the networking
capabilities and a sound legal structure; however, marketing natural products in a
competitive manner is the main risk.
Regarding agricultural bioprospecting in Colombia, it was found to be one of the most
developed sectors in the country (Database of GrupLAC-Colciencias), similar to that
reported by Chaparro and Vanegas (2010) in the Research on biological and genetic
resources in the country: agriculture research centers, in which it is stated that a high
percentage of research involving access to genetic resources, is intended to advance the
agricultural and livestock production sector, and have developed technical capabilities
and processes related to biotechnology. Currently, there is information and literature
reports in scientific papers and books, all related to a stage of bioprospecting, made by
various entities in partnership with the productive sector, generating products that have
economic returns, i.e., value added to the biological-genetic resource, primary products
and byproducts, and they have been successful bringing products to market. There are
several examples of suitable cultivated species, both introduced and from our diversity
(coffee, cacao, fruit, aromatics), however, there are some weaknesses that are in the
process, namely: lack of integrated knowledge of the raw material or the biological-
genetic organism; insufficient high quality raw material that supplements the
bioprospecting process at different stages, lack of developed agribusiness and logistic
deficits in marketing and quality control of products, realization of fair and equitable
benefits, and quantification of the economic value achieved by the development.
Colombia has some experience and technical expertise in different sectors of agriculture,
livestock, health and environment; for their development, it is necessary to continue to
implement programs and projects in each of the sectors which can be defined after
consultation processes. For example, in the agricultural sector, for greater success, it is
better to research and development products (with short, medium and long term results
for different bioprospecting industries) from a few crops and then to, after the experience,
replicate the model to other crops or products. It is advisable to use cacao, fruit (banana,
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cape gooseberry, passion flowers), coffee or any other crop that has wide acceptance
and an assured market presence, nationally and internationally, for at least ten years;
which requires research and continual innovation to remain competitive. Another
example is the development of the industries of natural products and enzymes derived
from plants, microorganisms or animals. It is recommended that sectors and a few species
be prioritized, where various academic entities, the productive sector, community and
government can advance to obtain added value from biological-genetic resources that
we possess.
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